Can TAE Life Sciences turn BNCT into a credible radio-immunotherapy platform for hard-to-treat cancers?
TAE Life Sciences’ BNCT study showed stronger boron delivery and immune effects in preclinical models. Read what this could change for oncology.
Pharma & Biotech